F. Vecchio

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.

Y. Dundar, J. Greenhalgh, A. Boland, 2021, The Cochrane database of systematic reviews.

Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination

D. Radice, C. Boni, T. De Pas, 2011, Chemotherapy.

Quantifying people living with HIV who would benefit from an alternative to daily oral therapy: Perspectives from HIV physicians and people living with HIV

J. Noone, G. Nachbaur, L. Finkielsztejn, 2020 .

Erlotinib Efficacy in NSCLC Patients with High Polysomy of Chromosome 7 and EGFR/KRas Wild-Type Tumors

F. de Marinis, M. Barberis, F. Conforti, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

First-line treatment of advanced epidermal growth factor receptor ( EGFR ) mutation positive non-squamous non-small cell lung cancer Review information Review type : Intervention

K. Dwan, Y. Dundar, J. Greenhalgh, 2015 .

Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092).

V. Valentini, C. Rossi, B. Barbaro, 2008, International journal of radiation oncology, biology, physics.

Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe

G. Nachbaur, B. Akinwunmi, L. Finkielsztejn, 2021, European journal of public health.

The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory study

D. Radice, A. Goldhirsch, A. Delmonte, 2014, Psycho-oncology.

Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries

G. Nachbaur, B. Akinwunmi, L. Finkielsztejn, 2021, Sexually Transmitted Infections.

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.

Y. Dundar, J. Greenhalgh, A. Boland, 2021, The Cochrane database of systematic reviews.

Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets.

M. Zucchetti, F. D. De Braud, A. Delmonte, 2014, The Oncologist.